News
Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...
The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and ...
Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.
A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.
Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.
The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.
Children with sickle cell disease can come together for a week of recreation and learning at Camp Hope in North Carolina.
Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell disease, a study reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results